Large and Small Molecule Contract Research
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
254
NCT06291948
A Clinical Study With Adalimumab Biosimilar
Phase: Phase 1
Role: Collaborator
Start: Aug 1, 2022
Completion: Oct 20, 2023
NCT06943378
Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy Adults
Role: Lead Sponsor
Start: May 16, 2025
Completion: Oct 31, 2027
Loading map...